Bio-Medical Applications Of Pennsylvania Inc is categorized under Blood Related Health Services in Philadelphia, PA .
Bio-Medical Applications Of Pennsylvania Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 621991 by the NAICS.
If you are seeking more information, feel free to contact Mary Garber at the company’s branch by writing to 900 East Howell St, Philadelphia, Pennsylvania PA 19149 or by phoning (215) 831-6170. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Bio-Medical Applications Of Pennsylvania Inc |
Contact Person: | Mary Garber |
Address: | 900 East Howell St, Philadelphia, Pennsylvania 19149 |
Phone Number: | (215) 831-6170 |
Annual Revenue (USD): | Unknown |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Blood Related Health Services |
SIC Code: | 8099 |
NAICS Code: | 621991 |
Share This Business: |
Bio-Medical Applications Of Pennsylvania Inc was started in 0 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 621991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Mary Garber for inquiries that concern Bio-Medical Applications Of Pennsylvania Inc by calling the company number (215) 831-6170, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Of Pennsylvania Inc can be found at the coordinates 40.038255,-75.091424 as well as the street address 900 East Howell St in Philadelphia, Pennsylvania 19149.
For its online presence, you may visit Bio-Medical Applications Of Pennsylvania Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.